Curcumin Efficacy and Safety in COVID-19 Infection

The current study is the first human clinical trial to evaluate curcumin efficacy and safety in COVID-19 infection. Results suggest curcumin can significantly improve recovery time from mild-to-moderate COVID-19 infection. Further high-quality, double-blind, randomised controlled trials with a larger sample size are required to assess the study's clinical significance, particularly in patients with a more severe form of infection…. but hey, we need to start the studies somewhere.